Concord Biotech Limited
- Stock
- CONCORDBIO
- NSE
- ₹632.60−5.96%
- Delayed close, 06 Nov
Details
- INE338H01029
- Healthcare
- Pharmaceuticals
- Face value ₹1
- Market cap ₹13,236 Cr
Paid for 3 years without a break
Dividend per share by FY
| Financial year | Total dividend |
|---|---|
| FY 2024–25 | ₹4.38 |
| FY 2025–26 | ₹5.35 |
| FY 2026–27 | ₹3.78 |
TTM payout
₹3.78
1 payout in 12 months
Yield
0.60%
Dividend yield · trailing 12 months
52-wk closing range ₹507.40 – ₹793.75 · split-adjusted
Yield and payout totals recalculated 08 Nov 2026.
Came to market
- Listed
- 18 Aug 2023
- 3 years 2 months ago
- Issue price
- ₹741.00
- at the offer
- First dividend
- 10 months
- after listing
Recent payouts
· 3 on record since FY 2024–25| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 24 Jul 2026 | Final | same day | ₹3.78* |
| 03 Sep 2025 | Final | same day | ₹5.35* |
| 21 Jun 2024 | Final | 22 Jun 2024 | ₹4.38* |
Amounts marked * were restated for a later split or bonus so they compare with today’s shares. Switch to “as filed” to see what was actually declared at the time — that is the figure on an old broker statement.
Income calculator
₹596
Expected income per year, before tax, at the current 0.60% yield
≈ 158 shares at ₹632.60, using ₹99,951 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.